Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
11.93
-0.01 (-0.08%)
Aug 29, 2025, 4:00 PM - Market closed
Roivant Sciences Stock Forecast
Stock Price Forecast
The 2 analysts that cover Roivant Sciences stock have a consensus rating of "Buy" and an average price target of $15.25, which forecasts a 27.83% increase in the stock price over the next year. The lowest target is $12.5 and the highest is $18.
Price Target: $15.25 (+27.83%)
Analyst Consensus: Buy
* Price targets were last updated on Jun 18, 2025.
Analyst Ratings
The average analyst rating for Roivant Sciences stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 2 | 2 | 2 | 2 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 4 | 4 | 4 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +50.88% | Jun 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +50.88% | May 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +50.88% | Apr 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +50.88% | Feb 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +50.88% | Nov 13, 2024 |
Financial Forecast
Revenue This Year
25.75M
from 29.05M
Decreased by -11.38%
Revenue Next Year
98.13M
from 25.75M
Increased by 281.14%
EPS This Year
-1.42
from -0.24
EPS Next Year
-1.37
from -1.42
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 49.6M | 222.7M | |||
| Avg | 25.7M | 98.1M | |||
| Low | 9.1M | 23.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 70.6% | 764.9% | |||
| Avg | -11.4% | 281.1% | |||
| Low | -68.7% | -8.6% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.24 | -0.99 | |||
| Avg | -1.42 | -1.37 | |||
| Low | -1.98 | -1.92 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.